Topic: Health

Scientists at Washington University School of Medicine have discovered a new way that mRNA vaccines work against cancer. They found that even when one type of immune cell is missing, another type can still trigger a strong attack on tumors.

The success of mRNA vaccines during the COVID-19 pandemic has led to new ways to fight cancer. Researchers are testing these vaccines against melanoma, small cell lung cancer, bladder cancer, and other types of cancer. A study from Washington University School of Medicine in St. Louis has uncovered a hidden feature of how these cancer vaccines work.

In experiments with mice, scientists found that mRNA cancer vaccines remained effective even when an immune cell called cDC1 was missing. Instead, another type of immune cell called cDC2 stepped in to trigger a strong attack against tumors. This discovery offers new insights into how the immune system responds to mRNA vaccines and could help researchers design more effective cancer vaccines.

mRNA vaccines deliver genetic instructions that tell immune cells to produce small pieces of protein. These protein fragments train the immune system to recognize and attack cells carrying the same proteins. For cancer vaccines, the proteins are chosen because they are unique to tumors, allowing immune cells to identify and destroy cancer cells while leaving healthy tissue largely unaffected.

A group of immune cells called dendritic cells plays a central role in this process by producing the protein fragments from the mRNA instructions. Another type of immune cell, called T cells, then seeks out and destroys cells carrying those proteins.

Why It Matters

This discovery could lead to more effective cancer treatments for people in India and around the world. It also highlights the potential of mRNA vaccines to fight other diseases beyond COVID-19.

Key Facts

• Scientists at Washington University School of Medicine have discovered a new way that mRNA vaccines work against cancer.
• The study found that another type of immune cell called cDC2 can trigger a strong attack on tumors when one type is missing.
• mRNA vaccines deliver genetic instructions that tell immune cells to produce small pieces of protein.
• These protein fragments train the immune system to recognize and attack cells carrying the same proteins.
• The study was published in the journal Nature on April 15, 2026.

Key Terms

mRNA

A type of genetic material that carries instructions for making proteins.

cDC1 and cDC2

Two types of immune cells that help trigger a strong attack on tumors.

T cells

A type of immune cell that seeks out and destroys cells carrying specific proteins.

Implications

This discovery could lead to more effective cancer treatments for people in India and around the world. It also highlights the potential of mRNA vaccines to fight other diseases beyond COVID-19.